Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Genetic Predictors of the Development and Recurrence of Graves’ Disease
source: Physiological Research / Academia Scientiarum Bohemoslovaca
year: 2018
authors: Vejrazkova D, Vcelak J, Vaclavikova E, Vankova M, Zajickova K, Duskova M, Vrbikova J, Bendlova B
summary/abstract:Graves’ disease affects approximately 3 % of women and 0.5 % of men. The first-choice therapy is based on the administration of thyrostatic drugs. However, approximately half of patients relapse within two years of discontinuation. These patients must then decide whether to re-initiate thyrostatics, which may have serious side effects, or to undergo surgery or radioiodine treatment.
Familial forms of Graves’ disease indicate a significant genetic component, with twin studies demonstrating a contribution of genetic factors up to 70-80 %. The autoimmune nature of the disease involves the human leukocyte antigen (HLA) complex, which has a decisive impact on each individual’s immune response. Within HLA, some variants of the DRB1, DQA1 and DQB1 genes appear to be possible predictors of the development and recurrence of Graves’ disease.
Outside the HLA region, many variants of immunocompetent genes have also been identified as potential Graves’ disease predictors. Apart from the immune system, some thyroid-specific genes have been described in relation to the disease. Here, we present current knowledge regarding the genetic components involved in the development and recurrence of Graves’ disease. Further, we present original pilot results from a cohort of Czech Graves’ disease patients regarding the HLA variants.
organization: Institute of Endocrinology, Czech Republicread more full text
myBinderRelated Content
-
Surgical Management of Graves’ – Dr. Kevin Brumundhttps://www.youtube.com/watch?v=0BfIbnrv...
-
Graves’ Disease Treatment for Someone in Their 20sHyperthyroidism triggered by Graves’ d...
-
Graves’ DiseaseGraves disease is an autoimmune disorder...
-
Thymic Hyperplasia Associated With Graves’ Disease: Pathophysiology and Proposed Management AlgorithmBackground: The association between Gra...
-
Management of Endocrine Disease: Arguments for the Prolonged Use of Antithyroid Drugs in Children With Graves’...Graves' disease is an autoimmune disorde...
-
A Pain in the Neck: News Reporting on Graves’ DiseaseMany different illnesses exist, and it i...
-
The Second Antithyroid Drug Treatment is Effective in Relapsed Graves’ Disease Patients: A Median 11-Year Foll...Background: Antithyroid drug (ATD) is a...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Google